Symbicort Aerosol
Product Images NDC 50090-1403

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Symbicort (NDC 50090-1403). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure1bodytext)

Line graph depicting percent change from baseline in predicted FEV1 over 12 weeks of treatment with SYMBICORT 160/4.5 mcg (two inhalations twice daily), budesonide 160 mcg (two inhalations twice daily), formoterol 4.5 mcg (two inhalations twice daily), budesonide 160 mcg plus formoterol 4.5 mcg (two inhalations twice daily), and placebo. The y-axis shows percent change from baseline, and the x-axis shows weeks of treatment, illustrating treatment effects over time.*

FDA Label Image

Figure 2 (Figure2bodytext)

A line graph showing percent change from baseline in predose FEV1 over 12 weeks for different treatments including Symbicort 80/4.5 mcg (two inhalations twice daily), Budesonide 80 mcg (two inhalations twice daily), Formoterol 4.5 mcg (two inhalations twice daily), and placebo. The graph plots time in weeks on the x-axis and percent change on the y-axis, indicating comparative lung function improvements.*

FDA Label Image

Figure 3 (Figure3bodytext)

A line graph showing the percent change from baseline in FEV1 over 12 hours for different inhalation treatments. The treatments include SYMBICORT 160/4.5 mcg, budesonide 160 mcg alone, formoterol 4.5 mcg alone, and their combination, all administered as two inhalations twice daily. The x-axis is labeled in hours from 0 to 12, and the y-axis shows percent change from -10 to 25.*

FDA Label Image

Figure 4 (Figure4bodytext)

A line graph showing percent change from baseline in FEV1 over 12 hours, comparing multiple treatment groups including SYMBICORT 160/4.5 mcg, Budesonide 160 mcg, Formoterol 4.5 mcg, Budesonide plus Formoterol combination, and placebo. The x-axis represents time in hours, and the y-axis shows percent change in FEV1.*

FDA Label Image

Figure 5 (Figure5bodytext)

A line graph comparing the change from baseline in 1-hour post-dose FEV1 (L) over 12 weeks between SYMBICORT 80/4.5 mcg and Budesonide 80 mcg, both administered as two inhalations twice daily. The graph includes data points with lines for each treatment and a patient number table at assessments weeks 0, 1, 4, 8, and 12.*

FDA Label Image

Figure 6 (Figure6bodytext)

A line graph depicting the percent change from baseline in pre-dose FEV1 over 6 months of treatment across five groups: SYMBICORT MDI 160/4.5 mcg, Budesonide 160 mcg, Formoterol 4.5 mcg, Budesonide 160 mcg plus Formoterol 4.5 mcg, and placebo. Data points for each group are plotted monthly with sample sizes listed below the x-axis.*

FDA Label Image

Figure 7 (Figure7bodytext)

A line graph depicting percent change from baseline in 1-hour post-dose FEV1 over 6 months for different treatments: SYMBICORT MDI 160/4.5 mcg, Budesonide 160 mcg, Formoterol 4.5 mcg, Budesonide 160 mcg + Formoterol 4.5 mcg, and placebo. The graph includes data points and sample sizes at various time points, comparing these respiratory inhalation treatments.*

FDA Label Image

Budesonide Structural Formula (Image 01)

Chemical structure diagram showing the molecular structures of Budesonide and Formoterol Fumarate Dihydrate, the active ingredients in SYMBICORT aerosol inhalation product by A-S Medication Solutions.*

FDA Label Image

Structural Fumarate (Image 02)

Chemical structure diagram showing the molecular arrangement of Budesonide and Formoterol Fumarate Dihydrate, the active ingredients in SYMBICORT aerosol inhalation.*

FDA Label Image

Figure 1 (Image 03)

An illustration diagram of the SYMBICORT inhaler device showing labeled parts including the counter, inhaler body, canister inside, mouthpiece, strap, and mouthpiece cover. The diagram visually explains the components of the aerosol inhaler used for respiratory administration.*

FDA Label Image

Figure 2 (Image 04)

An instructional illustration showing hands removing the protective cap from the mouthpiece of an inhaler device. Blue arrows indicate the direction to pull the cap away from the inhaler. The device resembles an inhalation aerosol. The figure is labeled as Figure 2.*

FDA Label Image

Figure 3 (Image 05)

An illustration showing a hand holding a red aerosol inhaler with a removable cap. The inhaler is being operated to release a spray from the mouthpiece, demonstrating correct usage technique for a respiratory aerosol inhalation device.*

FDA Label Image

Figure 4 (Image 06)

An instructional illustration showing hands using an inhaler with a removable mouthpiece. The diagram demonstrates cleaning the inhaler by rinsing the mouthpiece area, with water drops depicted falling onto an open palm below. The device resembles a respiratory aerosol inhaler.*

FDA Label Image

Figure 5 (Image 07)

An instructional illustration showing a person using a red Symbicort aerosol inhaler. The person is holding the inhaler near their mouth with the mouthpiece uncovered, demonstrating the proper inhalation technique for respiratory use.*

FDA Label Image

Counter (arrow pointing to 80)

An instructional diagram showing a circular dose counter dial with numeric increments from 0 to 120. The counter arrow points around 80, indicating the remaining doses on the device, likely representing part of a Symbicort inhaler dose counter mechanism.*

FDA Label Image

Counter (arrow pointing to 15)

An illustration of a circular dose counter dial for an inhalation aerosol product. The dial is numbered from 0 to 120 in increments of 10, with the current indicator pointing approximately to 25, showing the remaining doses available.*

FDA Label Image

Label Image (Lbl500901403)

SYMBICORT 160/4.5 aerosol inhaler label from A-S Medication Solutions. The label includes the product name, active ingredients Budesonide and Formoterol Fumarate Dihydrate, dosage strength 160/4.5, directions for use with 120 inhalations per container, storage instructions to keep between 40 to 77 degrees Fahrenheit, and a barcode. The label clearly identifies the manufacturer Libertyville, Illinois, and includes prescription and distribution information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.